docetaxel anhydrous has been researched along with Cancer of Cervix in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.00) | 18.2507 |
| 2000's | 14 (28.00) | 29.6817 |
| 2010's | 21 (42.00) | 24.3611 |
| 2020's | 12 (24.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, G; Nakanishi, K; Okazaki, S; Suzuki, S | 1 |
| Fan, S; Feng, Y; Hou, T; Liu, X; Shan, M; Wang, J; Zhang, Y; Zou, W | 1 |
| Song, Y; Wang, S | 1 |
| Kanao, H; Koike, R; Kurihara, N; Nomura, H; Omatsu, K; Sekizawa, A; Yunokawa, M | 1 |
| Chen, X; Huang, X; Lin, G; Liu, G; Ma, J; Mei, L; Shu, X; Wang, X; Wang, Y; Yang, Y; Ying, Y; Zhao, Y; Zuo, A | 1 |
| Bai, Z; Cai, Q; Cao, X; Liu, J; Ouyang, Y; Su, J; Wang, Y; Xu, Q | 1 |
| Broggini, M; Cisse, O; Falasca, M; Guffanti, F; Gulluni, F; Hirsch, E; Maffucci, T; Mavrommati, I; Oh, LCR; Quraishi, M; Sarvananthan, A; Schlatter, JN; Suthanthirakumaran, M | 1 |
| Bannister, AH; Bromma, K; Chithrani, DB; Chow, RL; Cicon, L; Howard, P; Monica, M; Schuemann, J; Sung, W | 1 |
| Chen, X; Han, W; Wan, J; Wang, H; Xie, B | 1 |
| Chen, R; Chen, Y; Hou, W; Ji, P; Jiang, G; Liou, Y; Su, Y; Xie, Y; Zhang, C; Zhang, D; Zhang, M | 1 |
| Chen, F; Du, S; Fu, J; Li, M; Ma, Z; Pei, J | 1 |
| Liang, MR; Liu, H; Wang, YN; Zeng, SY; Zhong, ML | 1 |
| Li, R; Liu, B; Liu, F; Liu, Q; Meng, F; Wang, L; Wang, Q; Wei, J; Xie, C; Yen, YT; Yu, L | 1 |
| Kigawa, J; Nagao, S; Nakamura, K; Sato, S; Shimada, M; Shoji, T; Sueoka, K; Takehara, K; Tokunaga, H; Yamaguchi, S | 1 |
| Chen, H; Feng, L; Liu, Y; Liu, Z; Lu, W; Lv, F; Sui, L; Wang, J; Wei, G | 1 |
| Kigawa, J; Kiyokawa, T; Kojima, A; Mikami, Y; Nagao, S; Nishimura, R; Shimada, M; Sugiyama, T; Takeshima, N; Teramoto, N | 1 |
| Feng, SS; Huang, L; Mei, L; Tan, C; Tao, W; Zeng, X | 1 |
| Bian, D; Du, W; Feng, X; Fu, C; Wang, X; Zhao, Y | 1 |
| Eskander, RN; Tewari, KS | 1 |
| Gao, Y; Huang, L; Liu, J; Liu, K; Ma, Y; Mei, L; Ming, P; Tang, X; Wang, Z; Zeng, X; Zhang, J | 1 |
| Guo, Z; Jiang, C; Li, J; Pei, SY; Si, TB; Wang, Q; Zhao, J | 1 |
| Cao, W; Feng, SS; Huang, L; Li, Z; Liu, G; Mei, L; Wang, L; Zeng, X | 1 |
| Caltagirone, C; Falchi, AM; Hyde, ST; Lippolis, V; Meli, V; Monduzzi, M; Murgia, S; Obiols-Rabasa, M; Rosa, A; Schmidt, J; Talmon, Y | 1 |
| Chen, G; Guan, R; Hu, S; Su, X; Wang, Y; Wu, J; Xu, W; Zhai, L | 1 |
| Fujiwara, K; Kigawa, J; Nagao, S; Nishimura, R; Shimada, M; Shoji, T; Sugiyama, T; Takeshima, N; Takizawa, K; Yamaguchi, S | 1 |
| Liu, G; Mei, L; Sheng, Y; Tao, W; Xu, G; Yu, X; Zhang, J | 1 |
| Alvarez, EA; Crisp, MP; Lambrou, NC; Lucci, JA; Mendez, LE; Pearson, JM; Wolfson, AH | 1 |
| Chang, CS; Chang, TH; Lin, JT; Shih, SC | 1 |
| Balis, FM; Bates, SE; Chen, CC; Chen, X; Draper, D; Figg, WD; Fojo, T; Gardner, ER; Kelly, RJ; Piekarz, RL; Robey, RW; Steinberg, SM; Venkatesan, AM | 1 |
| Cao, X; Guo, Y; Huang, H; Huang, X; Huang, Y; Lan, C; Liu, J; Wan, T; Zhang, Y | 1 |
| Fujiwara, K; Kigawa, J; Kitada, F; Nagao, S; Nishimura, R; Takekida, S; Terakawa, N; Yamaguchi, S; Yoshida, N | 1 |
| Chan, S; Davidson, SE; Harden, S; McMahon, T; Paul, J; Rai, D; Reed, NS; Symonds, RP | 1 |
| Du, W; Huang, M; Ke, QH; Lei, Y; Luo, F; Yang, JY; Zhou, SQ | 1 |
| Ding, JX; Han, JH; Ji, FZ; Ji, YL; Li, T; Pu, J; Qin, SS; Sun, JX; Tao, GZ; Yu, CH; Zhang, Y; Zhou, XL; Zhu, WG | 1 |
| Blohmer, JU; Breidenbach, M; Göhring, UJ; König, E; Kurbacher, CM; Mallmann, P; Rein, DT; Schmidt, T; Schöndorf, T | 1 |
| Bast, RC; Berek, JS; Bookman, MA; Cannistra, SA; Crum, CP; DePriest, PD; Garber, JE; King, L; Koh, WJ; Markman, M; McGuire, WP; Rose, PG; Rowinsky, EK; Rustin, GJ; Skates, SJ; Vasey, PA | 1 |
| Bologna, F; Boughen, JM; Cubero, A; Focaccia, G; Lacava, JA; Leone, BA; Machiavelli, MR; Ortiz, EH; Pérez, JE; Romero, AO; Scenna, M; Suttora, G; Vallejo, CT; Vicente, H | 1 |
| Fukaya, T; Maeda, N; Oguri, H | 1 |
| Fujiwara, K; Ishikawa, H; Kohno, I; Koike, H; Nagao, S; Oda, T; Tanaka, H | 1 |
| Attarpour, M; Balcer-Kubiczek, EK; Jiang, J; Kennedy, AS; Suntharalingam, M | 1 |
| Johnston, CM; McMeekin, DS; Pearl, ML | 1 |
| Blessing, JA; Garcia, AA; Roman, LD; Vaccarello, L | 1 |
| Hirabayashi, K; Kono, I; Noda, K; Ogita, Y; Taguchi, T; Terajima, Y; Yakushiji, M | 1 |
| Edwards, CL; Ende, K; Fishman, A; Freedman, RS; Kaplan, A; Kavanagh, JJ; Kieback, DG; Kudelka, AP; Levy, T; Mante, R; Steger, M; Verschraegen, CF | 1 |
| Orel, NF | 1 |
| Bombardelli, E; Cantelmo, F; Distefano, M; Fattorossi, A; Ferlini, C; Gaggini, C; Gallo, D; Mancuso, S; Proietti, E; Riva, A; Scambia, G | 1 |
| Kamura, T; Sugiyama, T; Ushijima, K | 1 |
| Britten, RA; Klein, K | 1 |
| Boghun, O; Hess, CF; Lehmann, J; Lücke, E; Pradier, O; Rave-Fränk, M; Schmidberger, H | 1 |
| Araki, S; Hongo, A; Kawanishi, K; Kodama, J; Kudo, T; Miyagi, Y; Yamamoto, J; Yoshinouchi, M | 1 |
3 review(s) available for docetaxel anhydrous and Cancer of Cervix
| Article | Year |
|---|---|
Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Mass Screening; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Taxoids; Topotecan; Uterine Cervical Neoplasms | 2014 |
[Taxotere in various solid tumors].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Taxoids; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1998 |
[New regimens for the treatment of gynecologic cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Humans; Irinotecan; Ovarian Neoplasms; Paclitaxel; Taxoids; Thrombocytopenia; Uterine Cervical Neoplasms | 2000 |
17 trial(s) available for docetaxel anhydrous and Cancer of Cervix
| Article | Year |
|---|---|
Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol.
Topics: Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Disease-Free Survival; DNA, Viral; Docetaxel; Female; Humans; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Papillomaviridae; Radiotherapy; Randomized Controlled Trials as Topic; Uterine Cervical Neoplasms | 2019 |
Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Uterine Cervical Neoplasms | 2021 |
Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoadjuvant Therapy; Taxoids; Uterine Cervical Neoplasms | 2018 |
Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Prognosis; Survival Rate; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Taxoids; Uterine Cervical Neoplasms | 2009 |
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Docetaxel; Female; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Quinolines; Taxoids; Uterine Cervical Neoplasms | 2011 |
Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Disease Progression; Docetaxel; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Quality of Life; Taxoids; Uterine Cervical Neoplasms | 2011 |
Early efficacy of taxotere and cisplatin chemo-radiotherapy for advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Prognosis; Remission Induction; Taxoids; Uterine Cervical Neoplasms | 2012 |
A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Follow-Up Studies; Humans; Hysterectomy; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Intensity-Modulated; Survival Rate; Taxoids; Uterine Cervical Neoplasms; Young Adult | 2013 |
Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Uterine Cervical Neoplasms | 2002 |
Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Survival Analysis; Taxoids; Uterine Cervical Neoplasms | 2003 |
Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Taxoids; Uterine Cervical Neoplasms | 2005 |
A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Oklahoma; Survival Analysis; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms | 2007 |
Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate; Taxoids; Uterine Cervical Neoplasms | 2007 |
[Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri].
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cystadenocarcinoma, Serous; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids; Thrombocytopenia; Uterine Cervical Neoplasms | 1994 |
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix.
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Uterine Cervical Neoplasms | 1996 |
30 other study(ies) available for docetaxel anhydrous and Cancer of Cervix
| Article | Year |
|---|---|
Allergy testing for Cremophor in a patient with cervical cancer with infusion reactions to paclitaxel and docetaxel.
Topics: Docetaxel; Female; Humans; Hypersensitivity; Paclitaxel; Polyethylene Glycols; Taxoids; Uterine Cervical Neoplasms | 2022 |
Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Propensity Score; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2023 |
Melatonin synergistically enhances docetaxel induced endoplasmic reticulum stress to promote apoptosis by suppressing NF-κB activation in cervical cancer.
Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Endoplasmic Reticulum Stress; Female; Humans; Melatonin; NF-kappa B; Uterine Cervical Neoplasms | 2023 |
Retrospective study of the efficacy and safety of docetaxel/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix.
Topics: Carboplatin; Carcinoma; Cervix Uteri; Chemotherapy, Adjuvant; Docetaxel; Female; Humans; Hysterectomy; Lymphatic Metastasis; Neoplasm Staging; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2023 |
Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Dendrimers; Docetaxel; Drug Carriers; Drug Liberation; Female; HeLa Cells; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Uterine Cervical Neoplasms; Vitamin E | 2019 |
Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Proliferation; Class II Phosphatidylinositol 3-Kinases; Docetaxel; Down-Regulation; Female; HeLa Cells; Humans; Male; Mice, Nude; PC-3 Cells; Prostatic Neoplasms; Random Allocation; Transfection; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.
Topics: Antineoplastic Agents; Biological Transport; Cell Survival; Docetaxel; Drug Synergism; Female; Gold; HeLa Cells; Humans; Metal Nanoparticles; Radiation-Sensitizing Agents; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2020 |
Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Docetaxel; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Prodrugs; Rats; Rats, Sprague-Dawley; Taxoids; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Fertility-preserving local excision under a hysteroscope with combined chemotherapy in a 6-year-old child with clear cell adenocarcinoma of the cervix: A case report and review of the literature.
Topics: Adenocarcinoma; Antineoplastic Agents; Cervix Uteri; Child; Docetaxel; Female; Humans; Hysteroscopy; Organ Sparing Treatments; Oxaliplatin; Uterine Cervical Neoplasms | 2020 |
Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Humans; In Vitro Techniques; Lipids; Mice; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Particle Size; Tissue Distribution; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Consolidation Chemotherapy; Docetaxel; Female; Humans; Hysterectomy; Liposomes; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms | 2020 |
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Gelatinases; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Neoplastic Stem Cells; Polyesters; Polyethylene Glycols; Pyrans; Uterine Cervical Neoplasms | 2021 |
Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification.
Topics: Animals; Cell Line, Tumor; Docetaxel; Female; Humans; Mice; Mucous Membrane; Nanoparticles; Polyethylene Glycols; Uterine Cervical Neoplasms | 2021 |
Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer.
Topics: Animals; Antineoplastic Agents; Cholic Acid; Docetaxel; Female; HeLa Cells; Humans; Lactic Acid; Mice; Mice, SCID; Nanomedicine; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Taxoids; Uterine Cervical Neoplasms; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Angiography; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Prognosis; Taxoids; Uterine Cervical Neoplasms | 2013 |
Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Humans; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Succinates; Taxoids; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2014 |
Comparative study of phosphorylated histone H2AX expressions in the cervical cancer patients of pre- and post-neoadjuvant chemotherapy. .
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Histones; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2015 |
Porphine functionalized nanoparticles of star-shaped poly(ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 1000 succinate biodegradable copolymer for chemophotodynamic therapy on cervical cancer.
Topics: Absorbable Implants; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Diffusion; Docetaxel; Female; HeLa Cells; Humans; MCF-7 Cells; Nanocapsules; Photochemotherapy; Polyesters; Polyethylene Glycols; Porphyrins; Radiation-Sensitizing Agents; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms; Vitamin E | 2015 |
Docetaxel-Loaded Fluorescent Liquid-Crystalline Nanoparticles for Cancer Theranostics.
Topics: Antineoplastic Agents; Cell Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Fluorescence; HeLa Cells; Humans; Liquid Crystals; Molecular Structure; Nanoparticles; Particle Size; Structure-Activity Relationship; Taxoids; Theranostic Nanomedicine; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2015 |
Adjuvant effect of docetaxel on HPV16 L2E6E7 fusion protein vaccine in a mouse model.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; Capsid Proteins; Cell Line, Tumor; Cytotoxicity, Immunologic; Docetaxel; Female; Human papillomavirus 16; Humans; Immunity, Humoral; Mice; Mice, Inbred C57BL; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Recombinant Fusion Proteins; Repressor Proteins; Taxoids; Tumor Burden; Uterine Cervical Neoplasms; Vaccines, Synthetic | 2016 |
Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
Topics: Animals; Antineoplastic Agents; Aptamers, Nucleotide; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; HeLa Cells; Humans; Indoles; Lactic Acid; Mice, SCID; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Taxoids; Uterine Cervical Neoplasms; Vitamin E; Xenograft Model Antitumor Assays | 2016 |
Docetaxel, carboplatin and 5-fluorouracil (TCF) chemotherapy in patients with unresectable metastatic carcinoma of cervix.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fluorouracil; Humans; Middle Aged; Retrospective Studies; Taxoids; Uterine Cervical Neoplasms | 2010 |
Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 - IIB) cervical cancer: preliminary results of a single-institution experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Taxoids; Uterine Cervical Neoplasms | 2011 |
Progress in the management of gynecologic cancer: consensus summary statement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carcinoma; Combined Modality Therapy; Docetaxel; Drugs, Investigational; Female; Genital Neoplasms, Female; Humans; Immunotherapy; Infusions, Parenteral; Injections, Intraperitoneal; Mass Screening; Organoplatinum Compounds; Ovarian Neoplasms; Predictive Value of Tests; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Cervical adenocarcinoma treated with docetaxel and carboplatin.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Fatal Outcome; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Taxoids; Uterine Cervical Neoplasms | 2003 |
Cytotoxicity of docetaxel (Taxotere) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cells.
Topics: Cell Nucleus; Cell Survival; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Microscopy, Fluorescence; Mitotic Index; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Uterine Cervical Neoplasms; X-Rays | 2006 |
Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bridged-Ring Compounds; Cell Cycle; DNA, Neoplasm; Docetaxel; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Mice; Mice, Nude; Paclitaxel; Taxoids; Transplantation, Heterologous; Tubulin; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2000 |
Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-raf; Taxoids; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2000 |
Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ).
Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Taxoids; Time Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2001 |
Neoadjuvant treatment with docetaxel and the effects of irradiation for human ovarian adenocarcinoma and cervical squamous cell carcinoma in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; DNA, Single-Stranded; Docetaxel; Female; Humans; In Vitro Techniques; Neoplastic Stem Cells; Ovarian Neoplasms; Paclitaxel; Radiation-Sensitizing Agents; Taxoids; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |